Due Diligence in Healthcare Private Equity Transactions

Minimizing Regulatory, Corporate Practice of Medicine and Other Risks

Recording of a 90-minute CLE webinar with Q&A

Conducted on Thursday, May 2, 2019

Recorded event now available

or call 1-800-926-7926
Program Materials

This CLE webinar will guide to counsel in healthcare private equity transactions on due diligence measures that effectively identify and mitigate risks and liabilities. The panel will address the regulatory and corporate practice of medicine issues that should be considered during the due diligence process.


Private equity firms play an active role in healthcare deals. As with any healthcare deal, the parties involved in healthcare private equity transactions should conduct thorough due diligence before closing the deal. The parties should consider potential successor liability, pending or threatened litigation, current contracts that could trigger penalties, and more. Because healthcare entities are highly regulated, parties to these transactions should conduct significant healthcare regulatory due diligence.

Counsel should also review current ownership structures to minimize the risk of corporate practice of medicine issues. Other regulatory considerations during the due diligence process include compliance with Stark law, Anti-Kickback Statute, False Claims Act and HIPAA, as well as the state law equivalents.

Listen as our authoritative panel examines due diligence in healthcare private equity transactions and why the due diligence process should be carefully structured and implemented. The panel will discuss the legal issues that should be addressed in healthcare due diligence, including key healthcare risk areas and requirements, compliance programs, Medicare/Medicaid changes of ownership, licenses, and permits. The panel will offer best practices for conducting due diligence in healthcare transactions.



  1. Due diligence structure and implementation
  2. Legal issues/risks to address
    1. Successor liability
    2. Pending or threatened litigation
    3. Stark
    4. AKS
    5. FCA
    6. HIPAA
    7. Compliance programs
    8. Medicare/Medicaid CHOW
    9. Licenses
    10. Permits
  3. Best practices


The panel will review these and other key issues:

  • What hurdles do counsel encounter when involving private equity firms in healthcare transactions?
  • What are the key regulatory due diligence issues in healthcare private equity transactions?
  • What are the most effective processes that are being used to conduct healthcare due diligence in a timely and cost-effective manner?


Prives, Glenn
Glenn P. Prives

Of Counsel
McElroy Deutsch Mulvaney & Carpenter

Mr. Prives represents a range of healthcare clients and has experience in the areas of hospital-physician alignment,...  |  Read More

Souter, Patrick
Patrick D. Souter

Of Counsel
Gray Reed & McGraw

Mr. Souter is known for his legal and educational experience in the healthcare industry, making him a sought-after...  |  Read More

Other Formats
— Anytime, Anywhere

Strafford will process CLE credit for one person on each recording. All formats include program handouts. To find out which recorded format will provide the best CLE option, select your state:

CLE On-Demand Video